reviewTop 10% cited

Clinical Application of Inhibitors of Fibrinolysis

Drugs · 1985 · Vol. 29(3) · pp. 236–261

Blood transfusion and management Trauma, Hemostasis, Coagulopathy, Resuscitation Acute Ischemic Stroke ManagementAprotininTranexamic acidAntifibrinolyticMedicineAminocaproic acidFibrinolysisAnesthesiaPharmacologyMyocardial infarctionCardiopulmonary bypass

MeSH terms

AngioedemaAntifibrinolytic AgentsBlood PreservationCorneal DiseasesDrug InteractionsEpistaxisFemaleHemophilia AHemorrhageHumansIntrauterine DevicesAprotininKineticsMaleMyocardial Infarction

Citations

468

FWCI

3.13

field-weighted impact

References

214

Percentile

92%

vs. same field & year

Citations per year

Cited by

Tranexamic Acid

Drugs · 1999 · 994 citations

Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol)

Journal of Thoracic and Cardiovascular Surgery · 1989 · 539 citations

References

A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis

British journal of surgery · 1978 · 542 citations

ISOLATION FROM BEEF PANCREAS OF CRYSTALLINE TRYPSINOGEN, TRYPSIN, A TRYPSIN INHIBITOR, AND AN INHIBITOR-TRYPSIN COMPOUND

The Journal of General Physiology · 1936 · 518 citations

On the Regulation and Control of Fibrinolysis

Thrombosis and Haemostasis · 1980 · 1,135 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.